col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


37 Ergebisse       Seite 1

 [1] 
Springer-Verlag: Protein & Cell
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Mai―25 A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2 Zijing Jia, Kang Wang, Minxiang Xie, Jiajing Wu, Yaling Hu, Yunjiao Zhou, et al. (+29)
2 [GO] 2024―Apr―13 Structural basis for polyuridine tract recognition by SARS-CoV-2 Nsp15 Fumiaki Ito, Hanjing Yang, Z Hong Zhou, Xiaojiang S Chen
3 [GO] 2024―Mrz―05 Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy Chenxiang Xi, Zihui Yan, Dandan Bai, Yalin Zhang, Beiying Wang, Xiao Xiao Han, et al. (+13)
4 [GO] 2024―Mrz―04 Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion Song Xue, Yuru Han, Fan Wu, Qiao Wang
5 [GO] 2023―Jul―20 Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD Hui Sun, Tingting Deng, Yali Zhang, Yanling Lin, Yanan Jiang, Yichao Jiang, et al. (+24)
6 [GO] 2023―Jul―13 SARS-CoV-2 ORF8 does not function in the nucleus as a histone mimic Ping Liu, Junjie Hu, Lei Wang
7 [GO] 2023―Feb―06 Longitudinal proteomic investigation of COVID-19 vaccination Yingrui Wang, Qianru Zhu, Rui Sun, Yi Xiao, Lingling Huang, Yifan Hu, et al. (+9)
8 [GO] 2022―Okt―26 A core epitope targeting antibody of SARS-CoV-2 Simeng Zhao, Fengjiang Liu, Shizhen Qiu, Qiaoshuai Lan, Yiran Wu, Wei Xu, et al. (+17)
9 [GO] 2022―Sep―28 High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors Yi Zang, Mingbo Su, Qingxing Wang, Xi Cheng, Wenru Zhang, Yao Zhao, et al. (+27)
10 [GO] 2022―Aug―23 A CRISPR activation screen identifies genes that enhance SARS-CoV-2 infection Fei Feng, Yunkai Zhu, Yanlong Ma, Yuyan Wang, Yin Yu, Xinran Sun, et al. (+17)
11 [GO] 2022―Jul―29 Serosurvey for SARS-CoV-2 among blood donors in Wuhan, China from September to December 2019 Le Chang, Lei Zhao, Yan Xiao, Tingting Xu, Lan Chen, Yan Cai, et al. (+5)
12 [GO] 2022―Jul―29 Single-dose AAV-based vaccine induces a high level of neutralizing antibodies against SARS-CoV-2 in rhesus macaques Dali Tong, Mei Zhang, Yunru Yang, Han Xia, Haiyang Tong, Huajun Zhang, et al. (+29)
13 [GO] 2022―Jul―29 A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 Omicron in vivo Daming Zuo, Yu Chen, Jian-piao Cai, Hao-Yang Yuan, Jun-Qi Wu, Yue Yin, et al. (+13)
14 [GO] 2022―Apr―06 Targeting papain-like protease for broad-spectrum coronavirus inhibition Shuofeng Yuan, Xiaopan Gao, Kaiming Tang, Jian-Piao Cai, Menglong Hu, Peng Luo, et al. (+17)
15 [GO] 2022―Apr―06 SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation Yichen Li, Shuaiyao Lu, Jinge Gu, Wencheng Xia, Shengnan Zhang, Shenqing Zhang, et al. (+9)
16 [GO] 2022―Apr―04 Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques Chun-Chun Gao, Man Li, Wei Deng, Chun-Hui Ma, Yu-Sheng Chen, Yong-Qiao Sun, et al. (+21)
17 [GO] 2021―Sep―07 Persisting lung pathogenesis and minimum residual virus in hamster after acute COVID-19 Lunzhi Yuan, Huachen Zhu, Ming Zhou, Jian Ma, Rirong Chen, Liuqin Yu, et al. (+14)
18 [GO] 2021―Aug―02 Comprehensive analysis of RNA-seq and whole genome sequencing data reveals no evidence for SARS-CoV-2 integrating into host genome Yu-Sheng Chen, Shuaiyao Lu, Bing Zhang, Tingfu Du, Wen-Jie Li, Meng Lei, et al. (+8)
19 [GO] 2021―Apr―30 Convergent evolution of SARS-CoV-2 in human and animals Hang-Yu Zhou, Cheng-Yang Ji, Hang Fan, Na Han, Xiao-Feng Li, Aiping Wu, Cheng-Feng Qin
20 [GO] 2021―Apr―28 Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine Xingdong Zhou, Hui Wang, Qun Ji, Mingjuan Du, Yuexia Liang, Huanhuan Li, et al. (+15)
21 [GO] 2021―Apr―17 High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors Yao Zhao, Xiaoyu Du, Yinkai Duan, Xiaoyan Pan, Yifang Sun, Tian You, et al. (+20)
22 [GO] 2021―Mrz―26 Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2 Dan Zhao, Weifan Xu, Xiaofan Zhang, Xiaoting Wang, Yiyue Ge, Enming Yuan, et al. (+14)
23 [GO] 2020―Dez―12 Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection Rongjuan Pei, Jianqi Feng, Yecheng Zhang, Hao Sun, Lian Li, Xuejie Yang, et al. (+9)
24 [GO] 2020―Nov―25 Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody Fang Li, Meng Luo, Wenyang Zhou, Jinliang Li, Xiyun Jin, Zhaochun Xu, et al. (+12)
25 [GO] 2020―Nov―18 Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction Wenyu Fu, Yujianan Chen, Kaidi Wang, Aubryanna Hettinghouse, Wenhuo Hu, Jing-Quan Wang, et al. (+4)
26 [GO] 2020―Nov―09 Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang, et al. (+19)
27 [GO] 2020―Okt―08 Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang, et al. (+19)
28 [GO] 2020―Sep―26 Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection Wanyin Tao, Xiaofang Wang, Guorong Zhang, Meng Guo, Huan Ma, Dan Zhao, et al. (+9)
29 [GO] 2020―Sep―07 The impact of aging and COVID-19 on our immune system: a high-resolution map from single cell analysis Jing Yang, Hao Li
30 [GO] 2020―Aug―17 Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China Jing Yang, Peihua Niu, Lijuan Chen, Liang Wang, Li Zhao, Baoying Huang, et al. (+7)
31 [GO] 2020―Aug―11 A human circulating immune cell landscape in aging and COVID-19 Yingfeng Zheng, Xiuxing Liu, Wenqing Le, Lihui Xie, He Li, Wen Wen, et al. (+16)
32 [GO] 2020―Aug―06 Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase Yechun Xu, Hualiang Jiang
33 [GO] 2020―Aug―04 Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang, et al. (+19)
34 [GO] 2020―Aug―04 Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice Jinliang Wang, Lei Shuai, Chong Wang, Renqiang Liu, Xijun He, Xianfeng Zhang, et al. (+8)
35 [GO] 2020―Jul―15 Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients Jiangping He, Shuijiang Cai, Huijian Feng, Baomei Cai, Lihui Lin, Yuanbang Mai, et al. (+20)
36 [GO] 2020―Apr―17 Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids Bing Zhao, Chao Ni, Ran Gao, Yuyan Wang, Li Yang, Jinsong Wei, et al. (+10)
37 [GO] 2020―Feb―22 Puzzle of highly pathogenic human coronaviruses (2019-nCoV) Jing Li, Wenjun Liu
 [1] 

37 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec